Latest News for: q32

Edit

Proxy Results (Form 8-K) (Q32 Bio Inc)

Public Technologies 16 Jun 2026
) Item 5.07. Submission of Matters to a Vote of Security Holders. During the 2026 Annual Meeting of Stockholders (the "Annual Meeting") of Q32 Bio Inc ... Proposal No. 1 - Election of Class II Directors. ... Arthur Tzianabos, Ph.D ... Q32 Bio Inc ... (noodl.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Q32 Bio Inc)

Public Technologies 16 Jun 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... OMB Number. 3235-0287 ... 2 ... Q32 Bio Inc ... Q32 BIO INC., 830 WINTER STREET 3 ... Q32 BIO INC ... Q32 Bio Inc.
Edit

Initial Statement of Beneficial Ownership (Form 3) (Q32 Bio Inc)

Public Technologies 08 Jun 2026
) FORM 3. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C ... OMB Number. 3235-0104. Estimated average burden hours per response... 0.5. (Print or Type Responses) 1. Name and Address of Reporting Person * ... 2 ... Q32 Bio Inc. [QTTB] ... 5 ... 5) ... Q32 Bio Inc.
Edit

Q32 Bio Announces $55 Million Private Placement Financing (Form 8-K) (Q32 Bio Inc)

Public Technologies 27 May 2026
Q32 Bio Announces $55 Million Private Placement Financing ... - May 27, 2026 /PRNewswire/ - Q32 Bio Inc ... QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology ... Q32 Bio Inc.
Edit

Q32 Bio Announces $55 Million Private Placement Financing

PR Newswire 27 May 2026
WALTHAM, Mass., May 27, 2026 /PRNewswire/ -- Q32 Bio Inc ... QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies ... About Q32 Bio ... SOURCE Q32 Bio.
Edit

Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

The Galveston Daily News 05 May 2026
-- Bempikibart 36-week topline data readout from Part B of SIGNAL-AA Phase 2a clinical trial on-track for mid-2026 -- ....
Edit

Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update (Form 8-K) (Q32 Bio Inc)

Public Technologies 05 May 2026
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update ... WALTHAM, Mass.- May 5, 2026 - Q32 Bio Inc ... Q32 Bio expects to report 36-week topline results in mid-2026 ... About Q32 Bio ... Availability of Other Information About Q32 Bio.
Edit

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) (Q32 Bio Inc)

Public Technologies 05 May 2026
(previously Q32 Bio Inc.) and its consolidated subsidiaries prior to the Merger, and references to "the Company," "we," "us," "our" and other similar terms refer to the business and operations of Q32 Bio Inc.
Edit

Annual Report (Form ARS) (Q32 Bio Inc)

Public Technologies 30 Apr 2026
). The text version of this document is not available ... Q32 Bio Inc.
Edit

Additional Proxy Soliciting Materials (Form DEFA14A) (Q32 Bio Inc)

Public Technologies 30 Apr 2026
). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION ... Q32 Bio Inc ... Your Vote Counts! Q32 BIO INC 2026 Annual Meeting Vote by June 11, 2026 11.59 PM ET Q32 BIO INC. 830 WINTER STREET WALTHAM, MA 02451 V92532-P42416 You invested in Q32 BIO INC ... Q32 Bio Inc.
Edit

Proxy Statement (Form DEF 14A) (Q32 Bio Inc)

Public Technologies 30 Apr 2026
Q32 Bio Inc ... Q32 Bio Inc ... Notice is hereby given that the 2026 Annual Meeting of Stockholders (the "Annual Meeting") of Q32 Bio Inc ... Only Q32 Bio Inc ... Q32 BIO INC ... and the term "Legacy Q32" refers to Q32 Bio Operations Inc ... Q32 BIO INC.
Edit

Material Event (Form 8-K) (Q32 Bio Inc)

Public Technologies 24 Apr 2026
) Item 8.01. Other Events. As previously disclosed, on March 27, 2026, Q32 Bio Inc. (the "Company") entered into a Controlled Equity OfferingSM Sales Agreement (the "Sales Agreement") with Cantor Fitzgerald & Co ... Q32 Bio Inc.
Edit

Supplemental Prospectus (Form 424B5) (Q32 Bio Inc)

Public Technologies 24 Apr 2026
and referred to herein as Legacy Q32), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology (the "Merger") ... and referred to herein as Legacy Q32), with ...
Edit

Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference

Citizen Tribune 08 Apr 2026
WALTHAM, Mass., April 8, 2026 /PRNewswire/ -- Q32 Bio Inc ...
Edit

Material Agreement (Form 8-K) (Q32 Bio Inc)

Public Technologies 27 Mar 2026
) Item 1.01. Entry into a Material Definitive Agreement. On March 27, 2026, Q32 Bio Inc. (the "Company") entered into a Controlled Equity OfferingSM Sales Agreement (the "Sales Agreement") with Cantor Fitzgerald & Co ... Q32 Bio Inc.

Article Search

tools
×
×
×
×